Jordan Wesley Appleyard, Jenny F. Seligmann, Dion Morton, Faye Elliott, Kelly Handley, Bengt Glimelius, Gemma Hemmings, Daniel Bottomley, Philip Quirke, Laura Magill, Nicholas West, Andrew David Beggs, Christopher Williams. "FOxTROT: Predictive effects of
                    <i>ERBB2</i>
                    and
                    <i>ERBB3</i>
                    on neoadjuvant panitumumab benefit in
                    <i>RAS/BRAF</i>
                    wild-type (-wt) locally advanced colon cancer (LACC).." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.2_suppl.17